Common Clinical Research Interview Questions
Clinical research provides invaluable insights into the patient’s experience, their illness, and how they respond to treatments.
Preparing for a clinical research interview can be challenging; hence, knowing what questions could be asked can help prepare.
In this blog post, we will review some of the most common clinical research interview questions and offer tips on ensuring you get the answers you need.
What is clinical research or clinical trial, and why is it important?
Clinical research is a type of scientific investigation that involves testing new treatments, interventions, and/or diagnostics in human beings. Its purpose is to determine whether these new approaches are safe and effective. Clinical trials are a subset of clinical research and refer specifically to research studies in which people are randomly assigned to receive either the experimental or a controlled treatment (which could be a placebo or standard of care).
Why is clinical research important? Without clinical research, we have many medical advances we enjoy today. For example, cancer mortality rates have decreased significantly over the past few decades, largely thanks to advances in chemotherapy and other cancer treatments that were only possible because of clinical trials.
What is informed consent?
This can be one of the commonly asked clinical research interview questions. Informed consent is the process by which a participant for clinical research or their legally authorized representative is given information about a study before deciding whether to participate.
The information must include details about the purpose of the study, what procedures will be involved, and any risks and benefits associated with participation. It is important for participants to feel that they are able to make an informed decision about whether or not to participate and that they are free to quit the research at any time.
What are the adverse effects and reactions?
Some many potential adverse effects and reactions can occur during clinical research. The adverse effects may involve but are not limited to:
- Feeling dizzy or lightheaded
- Feeling nauseous or vomiting
- Having diarrhea
- Changes in appetite
- Trouble sleeping
- Anxiety or nervousness
Some of these reactions may be due to the medication or treatment being studied, while others may be unrelated. It is important to report all adverse effects and reactions to the research staff so that they can be monitored and addressed accordingly.
How is the safety of the participants ensured?
The safety of the participants is always the priority in any clinical research study. Many steps are taken before, during, and after a study to ensure the participants are safe. The study’s sponsor will develop a plan to ensure the participants are safe. This plan is called a risk management plan.
The sponsor will work with the investigators to identify the risks of participating in the study. They will then put together a plan to mitigate those risks. An internal team will review the plan at the sponsor and by an independent review board (IRB). Once the plan is approved, it will be implemented during the study.
There are many ways to keep participants safe during a clinical research study. These include ensuring that they are informed about the risks and benefits of participating before they enroll, providing them with 24/7 support throughout the study, and monitoring them closely for any adverse events.
What must people keep in mind before partaking in a clinical trial?
When considering participating in a clinical trial, patients should speak with their doctor to ensure the trial fits them well. They should also be aware of the risks and benefits of participating in the trial and their rights as a participant. Patients should also ensure they understand all aspects of the trial before agreeing to participate.
Can a participant continue working with a primary health provider while on trial?
There is no definitive answer to this clinical research interview question, as it depends on the individual participant’s situation. For example, some participants may feel comfortable continuing to see their regular healthcare provider while being involved in a clinical trial. In contrast, others may prefer to work with the research team exclusively. Ultimately, it is up to the participant to decide what will work best for them.
Can a participant withdraw from a trial halfway?
It is possible for a participant to quit a trial halfway, although it is discouraged. If a participant chooses to quit, they may be asked to sign a form releasing the research team from liability. The form will also state that the participant is aware that quitting the trial may affect the data collected and cause other participants problems.
Where does the need or idea for a trial come from?
The need or idea for a trial typically comes from the sponsor, a pharmaceutical company. The sponsor develops the protocol and submits it for approval to an institutional review board (IRB). Once approved, the sponsor recruits sites and investigators to participate in the trial.
Who sponsors clinical trials?
There are many different sponsors for clinical trials. The most common sponsors are pharmaceutical companies, academic medical centers, and federal agencies. However, there are also clinical trial sponsors, independent research organizations, hospitals, managed care organizations, and even individual physicians. In addition, many clinical trials are sponsored by patient advocacy groups or foundations.
Get confidence & support for your clinical research interview questions
Lifepoint is widely regarded as the best clinical research institute in Pune and India. It boasts the best-in-class infrastructure for conducting clinical trials and a vast and diversified pool of therapy-naive patients to draw from.
Find the support you require and explore their clinical research courses here!